ArticleMolecular therapy : the journal of the American Society of Gene Therapy2013

Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines.

Charlotte Pollard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.